Inspyr Therapeutics Inc., of Westlake Village, Calif., said it entered into definitive securities purchase agreements with institutional and accredited investors, for the private placement of shares of convertible preferred stock and warrants to purchase shares of common stock resulting in gross proceeds of approximately $1 million.